Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
A Wisconsin couple has filed a lawsuit against Minnesota-based Optum Rx and Walgreens for their son’s asthma-related death ...
The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...
Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...